Blackhawk Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$941K Sell
10,267
-262
-2% -$22.9K 0.31% 73
2026
Q1
$897K Sell
10,529
-1,226
-10% -$109K 0.33% 67
2025
Q4
$929K Buy
+11,755
New +$922K 0.35% 70
2021
Q1
Sell
-7,812
Closed -$603K 93
2020
Q4
$603K Sell
7,812
-1,099
-12% -$90.9K 0.52% 58
2020
Q3
$653K Sell
8,911
-3,606
-29% -$275K 0.59% 53
2020
Q2
$831K Sell
12,517
-1,029
-8% -$73.1K 0.99% 40
2020
Q1
$933K Buy
+13,546
New +$955K 0.83% 48
2018
Q4
Sell
-8,286
Closed -$555K 75
2018
Q3
$555K Buy
8,286
+1,516
+22% +$101K 0.78% 38
2018
Q2
$439K Buy
6,770
+414
+7% +$27.1K 0.5% 54
2018
Q1
$456K Buy
6,356
+576
+10% +$41.5K 0.39% 62
2017
Q4
$436K Buy
+5,780
New +$422K 0.38% 66

Other funds holding CL

Blackhawk Capital Partners's CL Position: Q2 2026 in Review

Blackhawk Capital Partners reduced its Colgate-Palmolive (CL) stake by 2.5% in Q2 2026, selling an estimated $22.9K and leaving 10,267 shares worth $941K. The position accounts for 0.31% of the portfolio, ranked #73.

Blackhawk Capital Partners first reported a position in CL in Q4 2017 and has held it in 11 quarters since. 610 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Blackhawk Capital Partners held 10,267 shares of Colgate-Palmolive worth $941K as of Q2 2026.
  • Blackhawk Capital Partners sold 262 Colgate-Palmolive shares in Q2 2026, an estimated $22.9K.
  • Colgate-Palmolive made up 0.31% of Blackhawk Capital Partners's portfolio in Q2 2026, its #73 holding.
  • Blackhawk Capital Partners first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 11 quarters since.
  • 610 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Blackhawk Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.